Skip to content
EMExaminer
EMExaminer
Toggle sidebar

Hemolyzed Potassium, Sine-Wave ECG: Treat First, Verify in Parallel

A hemolyzed potassium result does not settle the diagnosis in a dialysis patient with a dangerous ECG. Learn how to stabilize immediately while getting a repeat result you can interpret.

EMExaminer 5 min read
Two blood collection tubes on an emergency department work surface, one suggesting hemolysis, with a blurred monitor and dialysis tubing in the background.

A hemolyzed potassium result poses two separate questions: is the measured number accurate, and is the patient in immediate danger? In a dialysis patient with profound bradycardia, hypotension, and a markedly widened QRS, the second question may demand action before the first is settled.

Consider this illustrative scenario: an adult with end-stage renal disease who has missed recent dialysis arrives profoundly weak, with a pulse in the 30s. The ECG shows a broadening QRS, disappearing P waves, and a sine-wave-like appearance; the first chemistry sample reports a markedly elevated potassium, but the laboratory flags hemolysis.

The practical goal is not to choose between trusting the ECG and trusting the lab. It is to stabilize the plausible emergency while promptly checking whether the potassium result is reliable.

Separate the clinical signal from the sample

Finding What it suggests What it does not prove
Missed dialysis and new weakness A high pretest probability of potassium retention The exact potassium concentration
Hemolysis flag The reported potassium may be falsely increased That the patient’s potassium is normal
Wide-complex bradycardia with absent P waves Dangerous conduction disturbance; hyperkalemia is a major concern in this context That hyperkalemia is the only possible cause
Normal ECG No obvious ECG manifestation at that moment That severe hyperkalemia is absent

Hemolysis can release potassium from blood cells after collection, producing a falsely high result. Traumatic venipuncture, prolonged tourniquet use, and fist clenching can contribute. Separately, marked leukocytosis or thrombocytosis can cause other forms of pseudohyperkalemia and complicate interpretation. But a patient with renal failure and missed dialysis can have true hyperkalemia and a hemolyzed sample at the same time.

Nor is the ECG a potassium assay. Severe hyperkalemia can occur without classic ECG changes, and ECG abnormalities do not establish a precise potassium level. Wide-complex bradycardia also has other causes, including sodium-channel blocker toxicity, ischemia, and primary conduction disease. The history and rhythm pattern raise concern; they do not close the differential.

Stabilize and verify in parallel

In an unstable patient with new, dangerous conduction changes and a strong clinical reason to suspect hyperkalemia, do not wait for a clean repeat potassium before giving membrane-stabilizing treatment under local protocol. Put the patient on continuous monitoring, mobilize resuscitation support, and involve the renal team early. Meanwhile, ask someone to obtain a fresh sample and arrange urgent potassium removal if severe hyperkalemia remains likely.

If it can be done without delaying stabilization, collect the repeat specimen before potassium-shifting therapy such as insulin or a beta agonist. Calcium is different: it protects the myocardium but does not lower the measured serum potassium, so it need not be withheld while a repeat sample is arranged. In a rapidly deteriorating patient, treatment takes priority over ideal sample timing.

The sequence matters because the repeat result answers a different question depending on when it was drawn. A clean sample collected before potassium-shifting medication helps assess whether the first result was spurious. A potassium level measured after shifting therapy may be lower because treatment worked; that result cannot, by itself, prove the first sample was false.

Make the repeat result useful

Use a fresh, carefully collected specimen: avoid prolonged tourniquet time and repeated fist clenching, and alert the laboratory to the discordance. A point-of-care whole-blood potassium can provide rapid information, but many analyzers cannot detect hemolysis. Its result is useful context, not an automatic tie-breaker; check the capabilities of the device used in your department and confirm through an appropriate laboratory method.

If repeat results remain discordant, review how each specimen was collected, transported, and analyzed. A complete blood count can help identify extreme leukocytosis or thrombocytosis, and the laboratory can advise whether specimen type or processing might explain the discrepancy. The small studies suggesting that some hemolyzed results can be safely set aside involved carefully selected, lower-risk patients; their findings should not be applied automatically to a patient with dialysis dependence and hemodynamic instability.

Let the next result change the plan

A convincingly normal, clean potassium drawn before shifting therapy should prompt a fresh look at the rhythm and other causes of instability. Reassess the ECG, consider toxicologic and ischemic causes, and avoid reflexively repeating potassium-shifting medication solely because the first flagged sample was high. Continue monitoring while the discrepancy is resolved.

Conversely, a repeat elevated potassium supports true hyperkalemia, but the hemolysis flag still deserves attention if the number seems out of keeping with the clinical picture. A value obtained after insulin or a beta agonist must be interpreted against the treatment timeline. Document when each sample was drawn and what had already been given.

The two common errors are mirror images: dismissing a dangerous result because the sample was hemolyzed, or treating every flagged number as unquestionably real. In a high-risk patient, a sensible approach is neither blind trust nor delay: act on the immediate threat, obtain a better specimen, and revise the plan as the evidence arrives.

Practical takeaways

  • A hemolysis flag lowers confidence in the number; it does not rule out true hyperkalemia.
  • In an unstable, high-risk patient with dangerous ECG changes, do not delay membrane stabilization for repeat testing.
  • When feasible, obtain a clean potassium before shifting therapy; record sample and treatment times.
  • Check whether your point-of-care analyzer can detect hemolysis, and involve the laboratory when results conflict.
  • A normal ECG does not rule out severe hyperkalemia, and an abnormal ECG does not identify its cause by itself.

Frequently asked questions

Put your Emergency Medicine knowledge into practice

Build a focused session and turn what you have learned into exam-ready reasoning.

Keep learning

Case Discussion

DKA and a Positive Troponin: Injury Is Not Yet an Infarct

In DKA, an elevated troponin signals myocardial injury but does not identify its cause. Learn how serial ECGs, assay-based troponin trends, and evidence of ischemia guide ED decisions about ACS.

Case Discussion

Massive Hematemesis in the ED: When to Intubate—and When Not To

In massive upper GI bleeding, the airway decision turns on active emesis, the patient’s ability to clear blood, and mental-status trajectory—not simply the plan for endoscopy.

Case Discussion

Aortic Dissection With a Changing Pulse Exam: Recognizing Malperfusion

A pulse deficit that fluctuates can be an evolving warning, not reassurance. Learn how serial neurovascular findings guide recognition of possible branch-vessel malperfusion, the CTA question, and urgent escalation—without guessing the exact artery from one bedside exam.

We use cookies to enhance your experience. By clicking Accept, you agree to all analytics and advertising cookies. Terms of Use & Privacy Policy